Mirecule
Gaithersburg, US · Founded 2018 · 3 known investors
miRecule is a biotechnology company developing tissue-targeted RNA therapeutics for cancer and muscular dystrophy. Its DREAmiR platform uses genomic and outcome data from patients to identify disease-causing genetic changes and design RNA therapies to target them, currently focused on neuromuscular diseases.
Founders & leadership
AS
Anthony SalehExecutive Officer
Investors · 3
Reported raises · per SEC filings
Form D private placements$1.5MraisedNov 2019 · 3 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.